We believe your time and energy should be spent doing your science, making your discoveries, and improving human health.

In the mid-2010’s several regenerative medicine scientists and researchers came together to think about the industry and identified a specific need they all had: they were spending valuable time, money, and resources isolating specific cell types they needed from donor tissues; instead of spending their time doing their ground-breaking science with the primary cells they needed. They needed a source of different primary cell types that were readily available and produced reliable, repeated results.

Thus the Amnion Foundation was born.

Initially focused on the isolation, characterization, and provision of several different cell types from donated placenta and birth tissues, Amnion Foundation has since been able to apply those isolation skills to different organ systems. We provide donor-matched cells from a variety of organ systems: birth-tissues, lung, intestine, skin, and kidney for your NAMs and multi-cell micro-physiological systems.

DRIVING ADVANCEMENT THROUGH VALIDATION & INNOVATION

All of our cell types pass thorough quality control tests that ensure that the cells you receive are high-quality and produce reliable, repeated results. We guarantee reproducible results for every lot of cells we deliver through sterility, endotoxin, and mycoplasma testing, cell density and viability (through two different methods - one fluorescent and one visible stain) testing, functionality through immunophenotyping and functional assays, as well as visual assessment of the cells at different confluencies through the growth process. We pride ourselves on the rigorous testing procedures we have developed to ensure our customers are receiving the correct cells with the correct functionality without adding risk to their current culture systems.

Our multidisciplinary team integrates academic rigor with industry insight to deliver evidence-based scientific solutions. We leverage these attributes to apply effective isolation techniques to different organ systems to allow us to offer donor-matched cell lots for each organ system driving your abilities to integrate multiple cells types within a single micro-physiological model. We can also leverage these attributes and know to be able to include disease state cells within your model systems.

By combining comprehensive laboratory analysis, data-driven modeling, and field validation, Amnion Foundation demonstrates how precise experimentation can facilitate scalable implementation.